Mei-Yi Lin

642 total citations
12 papers, 536 citations indexed

About

Mei-Yi Lin is a scholar working on Molecular Biology, Genetics and Biotechnology. According to data from OpenAlex, Mei-Yi Lin has authored 12 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Biotechnology. Recurrent topics in Mei-Yi Lin's work include Virus-based gene therapy research (3 papers), Epigenetics and DNA Methylation (3 papers) and RNA Interference and Gene Delivery (3 papers). Mei-Yi Lin is often cited by papers focused on Virus-based gene therapy research (3 papers), Epigenetics and DNA Methylation (3 papers) and RNA Interference and Gene Delivery (3 papers). Mei-Yi Lin collaborates with scholars based in Hong Kong, China and United States. Mei-Yi Lin's co-authors include Dan Xie, Xin‐Yuan Guan, Fei-Meng Zheng, H F Kung, Yiji Liao, Y-X Zeng, HF Kung, Yangchao Chen, Wei‐Guo Zhu and Yi‐Xin Zeng and has published in prestigious journals such as Oncogene, Gut and Gene Therapy.

In The Last Decade

Mei-Yi Lin

11 papers receiving 530 citations

Peers

Mei-Yi Lin

MB

CR

ONCOL

GENET

EPIDE

Elena Federzoni Switzerland

Chi‐Hung Lin Taiwan

Toshina Ishiguro‐Oonuma Japan

Jennifer Jurkin Austria

Xing Yao China

Ping Zhu China

Masashi Iizuka Japan

Laura Cubitt United Kingdom

Valentina Karin‐Kujundžić Croatia

James Kinchen United Kingdom

Elena Federzoni Switzerland

Mei-Yi Lin

394 ×1.0

MB

160 ×1.2

CR

73 ×0.7

ONCOL

91 ×1.2

GENET

74 ×1.3

EPIDE

Citations per year, relative to Mei-Yi Lin Mei-Yi Lin (= 1×) peers Elena Federzoni

Countries citing papers authored by Mei-Yi Lin

Since Specialization

Citations

This map shows the geographic impact of Mei-Yi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei-Yi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei-Yi Lin more than expected).

Fields of papers citing papers by Mei-Yi Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei-Yi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei-Yi Lin. The network helps show where Mei-Yi Lin may publish in the future.

Co-authorship network of co-authors of Mei-Yi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Mei-Yi Lin. A scholar is included among the top collaborators of Mei-Yi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei-Yi Lin. Mei-Yi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Wong, Chun‐Ka, Yuen‐Kwun Wong, Yap‐Hang Chan, et al.. (2025). Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation. Journal of the American Heart Association. 14(9). e038668–e038668. 1 indexed citations

2.

Liu, Chen, Young‐Jun Park, Chengbao Ma, et al.. (2025). HKU25 clade MERS-related coronaviruses use ACE2 as a functional receptor. Nature Microbiology. 10(11). 2860–2874.

3.

Cai, Muyan, Fei-Meng Zheng, Hui Rao, et al.. (2011). EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies. Gut. 60(7). 967–976. 138 indexed citations

4.

Liao, Yiji, Fei-Meng Zheng, Wei‐Guo Zhu, et al.. (2011). EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin. Oncogene. 31(5). 583–594. 176 indexed citations

5.

Qian, Dong, Rui Jin, Yiji Liao, et al.. (2011). Anthracyclines disrupt telomere maintenance by telomerase through inducing PinX1 ubiquitination and degradation. Oncogene. 31(1). 1–12. 44 indexed citations

6.

Lin, Mei-Yi, et al.. (2010). Nuclear accumulation of glioma-associated oncogene 2 protein and enhanced expression of forkhead-box transcription factor M1 protein in human hepatocellular carcinoma.. PubMed. 25(10). 1269–75. 16 indexed citations

7.

He, Ming‐Liang, Bo Zheng, Jian Huang, et al.. (2009). Development of interfering RNA agents to inhibit SARS-associated coronavirus infection and replication.. PubMed. 15(3 Suppl 4). 28–31. 12 indexed citations

8.

Ng, Samuel S., David Chau, Hong Yao, et al.. (2008). Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy. Cancer Gene Therapy. 15(11). 723–732. 14 indexed citations

9.

Ng, Samuel S., Ying Gao, David Chau, et al.. (2007). A novel glioblastoma cancer gene therapy using AAV-mediated long-term expression of human TERT C-terminal polypeptide. Cancer Gene Therapy. 14(6). 561–572. 28 indexed citations

10.

Han, Yunghsiang S., et al.. (2006). Cleft lip and/or palate in a low-resource province in China. International Journal of Gynecology & Obstetrics. 93(2). 146–147. 2 indexed citations

11.

Luk, K.D.K., Kmc Cheung, Rui‐Hua Xu, et al.. (2003). Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Gene Therapy. 10(16). 1345–1353. 83 indexed citations

12.

Kung, H F, Mei-Yi Lin, Huanwen Chen, et al.. (2000). Induction of oocyte maturation by jun -N-terminal kinase (JNK) on the oncogenic ras -p21 pathway is dependent on the raf -MEK-MAP kinase signal transduction pathway. Cancer Chemotherapy and Pharmacology. 45(6). 441–449. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact